VALENTI, RAFFAELLA
 Distribuzione geografica
Continente #
NA - Nord America 1.741
EU - Europa 1.382
AS - Asia 288
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.417
Nazione #
US - Stati Uniti d'America 1.738
PL - Polonia 448
RU - Federazione Russa 398
IT - Italia 201
SE - Svezia 119
IE - Irlanda 110
SG - Singapore 87
CN - Cina 82
HK - Hong Kong 68
FI - Finlandia 30
IN - India 24
DE - Germania 22
GB - Regno Unito 19
UA - Ucraina 13
ES - Italia 12
JO - Giordania 11
TR - Turchia 6
CI - Costa d'Avorio 4
KR - Corea 4
NL - Olanda 4
VN - Vietnam 4
CA - Canada 3
CZ - Repubblica Ceca 3
FR - Francia 3
EU - Europa 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
TW - Taiwan 1
Totale 3.417
Città #
Warsaw 448
Santa Clara 261
Fairfield 236
Woodbridge 147
Chandler 118
Ashburn 114
Dublin 110
Houston 108
Seattle 98
Wilmington 83
Cambridge 80
Singapore 59
Florence 55
Lawrence 47
Altamura 46
Hong Kong 42
Beijing 41
Ann Arbor 38
Princeton 38
Mumbai 23
Jacksonville 21
Shanghai 19
Boston 16
Medford 16
Barcelona 11
Kent 10
New York 10
Boardman 9
Buffalo 7
San Diego 7
Falls Church 6
Cantù 5
Dearborn 5
Izmir 5
Los Angeles 5
Moscow 5
Munich 5
Phoenix 5
Abidjan 4
Andover 4
Dong Ket 4
Seoul 4
Brno 3
Detroit 3
Helsinki 3
Ponte Buggianese 3
Treviso 3
West Jordan 3
Frankfurt Am Main 2
Hounslow 2
Mcallen 2
Norwalk 2
Oxford 2
Pianoro 2
Prato 2
Redwood City 2
Salerno 2
Toronto 2
Verona 2
Washington 2
Ancona 1
Auckland 1
Bergamo 1
Bhavnagar 1
Bologna 1
Castelfiorentino 1
Cecina 1
Clamart 1
Council Bluffs 1
Fiesole 1
Gallarate 1
Hillsboro 1
Kilburn 1
Kunming 1
Langfang 1
Laurel 1
Legnano 1
Lemelerveld 1
Lonate Ceppino 1
London 1
Lyndhurst 1
Milan 1
Monte San Savino 1
Mountain View 1
Phitsanulok 1
Ravenna 1
Redmond 1
Rome 1
Romola 1
San Remo 1
Siena 1
Solignano 1
Southwark 1
Turin 1
Xiamen 1
Yubileyny 1
Totale 2.453
Nome #
Prediction of impaired performance in Trail Making Test in MCI patients with small vessel disease using DTI data 240
Is the oxidant/antioxidant status altered in CADASIL patients? 230
Treatment of vascular risk factors in patients with a diagnosis of Alzheimer's disease: A systematic review 216
Operationalizing mild cognitive impairment criteria in small vessel disease: The VMCI-Tuscany Study 163
Risk and Determinants of Dementia in Patients with Mild Cognitive Impairment and Brain Subcortical Vascular Changes: A Study of Clinical, Neuroimaging, and Biological Markers-The VMCI-Tuscany Study: Rationale, Design, and Methodology. 153
Diffusion Tensor Imaging to Map Brain Microstructural Changes in CADASIL 138
Circulating Biomarkers in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Patients 138
Cerebral microbleeds in patients with mild cognitive impairment and small vessel disease: The Vascular Mild Cognitive Impairment (VMCI)-Tuscany study 137
CADASIL in central Italy: A retrospective clinical and genetic study in 229 patients 123
The CADASIL scale: a screening tool to select patients for NOTCH3 gene analysis 122
Agreement between TOAST and CCS ischemic stroke classification: The NINDS SiGN Study. 120
Acetazolamide for the prophylaxis of migraine in CADASIL: a preliminary experience. 113
The Florence VAS-COG clinic: a model for the care of patients with cognitive and behavioral disturbances consequent to cerebrovascular diseases. 113
Mild cognitive impairment etiologic subtyping using pragmatic and conventional criteria: preliminary experience in the Florence VAS-COG clinic. 107
White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany Study. 103
Facial Affect Recognition in CADASIL Patients. 101
Influence of vascular risk factors and neuropsychological profile on functional performances in CADASIL: results from the MIcrovascular LEukoencephalopathy Study (MILES). 101
Stroke recurrence in an elderly CADASIL patient on aspirin discontinuation due to severe auto-immune thrombocytopenia 100
Major depression and bipolar disorders in CADASIL: a study using the DSM-IV semi-structured interview 97
The rehabilitation of attention in patients with mild cognitive impairment and brain subcortical vascular changes using the Attention Process Training-II. The RehAtt Study: rationale, design and methodology 97
High lipoprotein(a) serum levels in three CADASIL families. 96
Cerebral hemorrhages in CADASIL: report of four cases and a brief review. 93
Stroke Genetics Network (SiGN) study: design and rationale for a genome-wide association study of ischemic stroke subtypes. 92
Psychiatric disturbances in CADASIL: a brief review 85
Journal Club: Time trends in incidence, case fatality, and mortality of intracerebral hemorrhage 69
Mutation screening of HTRA1 gene in NOTCH3-negative patients with cerebral small vessel disease 66
Longitudinal changes in MoCA performances in patients with mild cognitive impairment and small vessel disease. Results from the VMCI-Tuscany Study 55
Effects of sapropterin on endothelium-dependent vasodilation in patients with CADASIL: a randomized controlled trial 55
Application of the DSM-5 Criteria for Major Neurocognitive Disorder to Vascular MCI Patients 53
Effect of Attention Training in Mild Cognitive Impairment Patients with Subcortical Vascular Changes: The RehAtt Study 50
Prevalence of Fabry disease and GLA variants in young patients with acute stroke: The challenge to widen the screening. The Fabry-Stroke Italian Registry 41
Totale 3.467
Categoria #
all - tutte 9.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.996


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020427 0 0 0 0 70 67 66 66 56 46 48 8
2020/2021277 26 22 15 38 20 32 9 18 32 28 20 17
2021/2022163 3 17 16 4 2 6 9 12 5 6 23 60
2022/2023553 56 143 28 28 31 90 65 20 53 0 32 7
2023/2024222 9 20 32 9 24 29 3 52 3 8 22 11
2024/2025868 64 148 89 231 336 0 0 0 0 0 0 0
Totale 3.467